ImmunoGen Announces Conference Call To Discuss Its Financial Results For Quarter Ended September 30

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the Company will host a conference call at 8:00 a.m. ET on Friday, October 28, 2016, to discuss ImmunoGen's financial results for the three-month period and fiscal year ended September 30, 2016. Management also will provide a brief update on the business.
MORE ON THIS TOPIC